Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Fluconazole (150mg) + Ivermectin (6mg) Tablet
Therapeutic Category
Antifungals
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10x5
Price
₹0/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Fucoziff IM Tablet contains Fluconazole 150mg + Ivermectin 6mg, a dual-action therapy for managing fungal and parasitic infections effectively. Fluconazole combats fungal overgrowth, while Ivermectin eliminates parasitic infestations, providing comprehensive infection control.
This combination is clinically preferred due to its broad-spectrum efficacy and patient tolerability, ensuring reliable results for acute and chronic infections. Patients experience faster recovery, reduced infection recurrence, and improved overall health.
For franchise partners, Fucoziff IM Tablet is a high-demand product in the antifungal and antiparasitic segment, offering strong market acceptance and consistent repeat prescriptions. Its dual-action formula makes it a profitable addition to specialty portfolios, boosting sales and business growth.
With rising incidences of fungal and parasitic infections, Fucoziff IM Tablet provides sustainable business opportunities, helping partners expand their footprint in infection care therapy.
Common side effects may include nausea, vomiting, headache, dizziness, or mild gastrointestinal disturbances. Some patients may experience transient skin rashes, fatigue, or liver enzyme changes. Severe or persistent reactions should be reported immediately to a healthcare professional.
Fucoziff IM Tablet is indicated for the treatment of fungal infections such as candidiasis and dermatophytosis, as well as parasitic infections including strongyloidiasis, scabies, and other susceptible parasitic infestations. It helps clear infections efficiently and reduces associated symptoms such as itching, inflammation, and discomfort.
Fucoziff IM Tablet should be taken strictly under medical supervision. It is contraindicated in patients with known hypersensitivity to Fluconazole, Ivermectin, or any component of the formulation. Liver function should be monitored during prolonged therapy, and caution is advised in patients with liver or kidney impairment.
Store Fucoziff IM Tablet in a cool, dry place below 25°C, protected from direct sunlight and moisture. Keep out of reach of children and do not use after the expiry date mentioned on the packaging.
Composition : Amorolfine I.P. 0.25% w/w Cream
Composition : Terbinafine, Ciprofloxacin, Metronidazole & Clobetasole Propionate Cream
Composition : Chlorhexidine Gluconate (0.20% w/w) + Silver Nitrate (0.20% w/w) cream
Composition : Clobetasole 0.05% + Neomycin 0.5% + Miconazole 2%
Composition : Hydroquinone (2% w/w) + Mometasone (0.1% w/w) + Tretinoin (0.025% w/w)
Composition : Ketoconazole (2% w/w) Cream
Composition : Ketoconazole (2% w/w) + Beclometasone (0.025% w/w)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination tablet is used in certain mixed parasitic, fungal, and dermatological infection conditions under physician supervision, making it a specialized anti-infective and dermatology product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from demand in dermatology clinics, parasitic infection management, and mixed infection cases where combination therapy is prescribed. It is used by physicians for targeted treatment in specific clinical scenarios.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Fluconazole + Ivermectin Tablet with monopoly rights, quality combination manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from specialist prescription demand in dermatology and infection segments, along with stable pharmacy movement when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this specialized anti-infective formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.